Nan Lin

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects

Yifan Zhang, Dayong Si, Xiaoyan Chen et al. · British Journal of Clinical Pharmacology · 2007 · 63 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

The Nrf2/PGC1α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer

Xinyue Deng, Nan Lin, Jiaying Fu et al. · Oxidative Medicine and Cellular Longevity · 2020 · 51 citations · Full text

Medicine, Oncology, Pharmacology +16

Selenium Causes Growth Inhibition and Apoptosis in Human Brain Tumor Cell Lines

Narayan Sundaram, Amit Pahwa, March D. Ard et al. · Journal of Neuro-Oncology · 2000 · 43 citations

Medicine, Oncology, Toxicology +11

PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback

Luyan Shen, Li Zhou, Meihui Xia et al. · Experimental Cell Research · 2020 · 33 citations

Medicine, Molecular Biology, Oncology +13

Monitoring Clinical–Pathological Grading of Hepatocellular Carcinoma Using MicroRNA-Guided Semiconducting Polymer Dots

Ze Zhang, Yuyang Wu, Nan Lin et al. · ACS Applied Materials & Interfaces · 2022 · 12 citations

Medicine, Molecular Biology, Oncology +17